Kindly MD (NAKA)
NASDAQ:NAKA
NAKA Stock Chart & Stats
$0.21
--
Market closed
$0.21
--
Day’s Range― - ―
52-Week Range$0.21 - $34.77
Previous CloseN/A
VolumeN/A
Average Volume (3M)30.98M
Market Cap
N/A
Enterprise Value$266.15M
Total Cash (Recent Filing)$22.58M
Total Debt (Recent Filing)$209.56M
Price to Earnings (P/E)―
Beta4.24
Next Earnings
Jun 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding690,018,250
10 Day Avg. Volume32,220,503
30 Day Avg. Volume30,978,537
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.14
Price to Sales (P/S)38.59
P/FCF Ratio-0.10
Enterprise Value/Market Cap10.00T>
Enterprise Value/Revenue146.13
Enterprise Value/Gross Profit-28.72
Enterprise Value/Ebitda-5.92
Forecast
1Y Price Target
$0.75Price Target Upside257.14% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.02
Revenue Forecast (FY)$46.60M
Bulls Say, Bears Say
Bulls Say
Acquisition ImpactAnalyst expects the pending acquisition of BTC Inc. to add meaningful revenue and provide an established digital-asset media platform that expands audience reach and monetization opportunities.
Bitcoin Treasury StrategyAnalyst highlights the company's Bitcoin treasury strategy and planned accumulation of Bitcoin as a potential driver of long-term asset appreciation and shareholder value.
Valuation SupportAnalyst's sum-of-the-parts valuation, combining media business cash flows with the projected value of accumulated Bitcoin, underpins a constructive price target.
Bears Say
Capital Requirements RiskAnalyst warns that further Bitcoin purchases or additional M&A may require new financing beyond current resources, creating dilution or debt risk.
Digital-asset Market WeaknessAnalyst notes a pullback in digital-asset prices and investor sentiment that has led to lowered revenue estimates for 2026–2027, pressuring growth expectations.
Profitability PressureAnalyst points to a larger adjusted EBITDA loss driven by one-time go-public expenses, which increases near-term profitability pressure and investor scrutiny.
Kindly MD News
NAKA FAQ
What was Kindly MD’s price range in the past 12 months?
Kindly MD lowest stock price was $0.21 and its highest was $34.77 in the past 12 months.
What is Kindly MD’s market cap?
Currently, no data Available
When is Kindly MD’s upcoming earnings report date?
Kindly MD’s upcoming earnings report date is Jun 26, 2026 which is in 77 days.
How were Kindly MD’s earnings last quarter?
Kindly MD released its earnings results on Mar 30, 2026. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of -$0.015 by $0.085.
Is Kindly MD overvalued?
According to Wall Street analysts Kindly MD’s price is currently Undervalued.
Does Kindly MD pay dividends?
Kindly MD does not currently pay dividends.
What is Kindly MD’s EPS estimate?
Kindly MD’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kindly MD have?
Kindly MD has 690,018,250 shares outstanding.
What happened to Kindly MD’s price movement after its last earnings report?
Kindly MD reported an EPS of $0.07 in its last earnings report, beating expectations of -$0.015. Following the earnings report the stock price went up 4.762%.
Which hedge fund is a major shareholder of Kindly MD?
Currently, no hedge funds are holding shares in NAKA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Kindly MD
Nakamoto Inc. develops and invests in a global portfolio of Bitcoin-native companies. The company provides commercial and financial infrastructure for the capital markets. The company was formerly known as Kindly MD, Inc. and change its name to Nakamoto Inc. in January 2026. The company was incorporated in 2019 and is based in Nashville, Tennessee.
NAKA Stock 12 Month Forecast
Average Price Target
$0.75
▲(257.14% Upside)
Technical Analysis
EyePoint Pharmaceuticals
―
Inhibrx Biosciences Inc
―
Rapport Therapeutics, Inc.
―
Sila Realty Trust, Inc.
―
Beta Bionics, Inc.
―
Ownership Overview
22.50% Insiders
1.20% Mutual Funds
8.88% Other Institutional Investors
66.20% Public Companies and
Individual Investors